Papadopoulos V, Guarneri P, Kreuger K E, Guidotti A, Costa E
Department of Anatomy and Cell Biology, Georgetown University School of Medicine, Washington, DC 20007.
Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5113-7. doi: 10.1073/pnas.89.11.5113.
The C6-2B glioma cell line, rich in mitochondrial receptors that bind with high affinity to benzodiazepines, imidazopyridines, and isoquinolinecarboxamides (previously called peripheral-type benzodiazepine receptors), was investigated as a model to study the significance of the polypeptide diazepam binding inhibitor (DBI) and the putative DBI processing products on mitochondrial receptor-regulated steroidogenesis. DBI and its naturally occurring fragments have been found to be present in high concentrations in C6-2B glioma cells, to compete against specific isoquinolinecarboxamide or 4'-chlorodiazepam binding to mitochondrial recognition sites with high affinity, and to stimulate mitochondrial pregnenolone formation. These data suggest that this cell type may express both the receptor and the putative agonist ligand to regulate steroidogenesis. Therefore, we propose to term this mitochondrial receptor MDR (mitochondrial DBI receptor) to indicate its responsiveness to DBI in steroid biosynthesis. In the present work, we show that mitochondria of C6-2B cells convert (22R)-22-hydroxycholesterol to pregnenolone by a mechanism blocked by aminoglutethimide. Immunoblotting confirmed the presence of relatively high levels of cytochrome P-450 cholesterol side-chain-cleavage enzyme in C6-2B cell mitochondria. Furthermore, isoquinolinecarboxamide binding sites associated with the 18-kDa mitochondrial polypeptide subunit of the MDR are abundant in C6-2B glioma cell mitochondria (Bmax approximately 30 pmol/mg protein) and are coupled to the regulation of steroid biosynthesis. Occupancy of MDRs with nanomolar concentrations of the naturally occurring polypeptide, DBI, as well as its naturally occurring processing product tetratriacontaneuropeptide [DBI-(17-50)] increases pregnenolone formation. Clonazepam and octadecaneuropeptide [DBI-(33-50)], which exhibit a higher affinity for gamma-aminobutyric acid type A receptors but a low affinity for MDR, were ineffective in stimulating pregnenolone synthesis. These findings provide evidence that C6-2B cells exhibit a significant steroidogenic activity which resembles that found in peripheral endocrine organs and they suggest that MDRs and DBI are involved in the regulation of glial cell steroidogenesis.
C6 - 2B胶质瘤细胞系富含与苯二氮䓬类、咪唑吡啶类和异喹啉羧酰胺(以前称为外周型苯二氮䓬受体)具有高亲和力结合的线粒体受体,该细胞系被作为一种模型来研究多肽地西泮结合抑制剂(DBI)及假定的DBI加工产物对线粒体受体调节的类固醇生成的意义。已发现DBI及其天然存在的片段在C6 - 2B胶质瘤细胞中高浓度存在,能以高亲和力竞争异喹啉羧酰胺或4'-氯地西泮与线粒体识别位点的结合,并刺激线粒体孕烯醇酮的形成。这些数据表明这种细胞类型可能同时表达受体和假定的激动剂配体来调节类固醇生成。因此,我们建议将这种线粒体受体称为MDR(线粒体DBI受体),以表明其在类固醇生物合成中对DBI的反应性。在本研究中,我们表明C6 - 2B细胞的线粒体通过一种被氨鲁米特阻断的机制将(22R)-22-羟胆固醇转化为孕烯醇酮。免疫印迹证实C6 - 2B细胞线粒体中存在相对高水平的细胞色素P - 450胆固醇侧链裂解酶。此外,与MDR的18 kDa线粒体多肽亚基相关的异喹啉羧酰胺结合位点在C6 - 2B胶质瘤细胞线粒体中丰富(Bmax约为30 pmol/mg蛋白质),并与类固醇生物合成的调节相关联。用纳摩尔浓度的天然存在的多肽DBI及其天然存在的加工产物三十四烷神经肽[DBI-(17 - 50)]占据MDR会增加孕烯醇酮的形成。对γ-氨基丁酸A型受体具有较高亲和力但对MDR具有低亲和力的氯硝西泮和十八烷神经肽[DBI-(33 - 50)],在刺激孕烯醇酮合成方面无效。这些发现提供了证据,表明C6 - 2B细胞表现出显著的类固醇生成活性,类似于在外周内分泌器官中发现的活性,并且表明MDR和DBI参与神经胶质细胞类固醇生成的调节。